ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Scrip’s Five Must-Know Things – 30 October 2023"
Episode Synopsis
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: did Pfizer miss out on Roivant/Roche deal?; Padcev/Keytruda combo impresses in bladder cancer at ESMO; biggest upfront ever in Daiichi/Merck deal; Rybrevant at ESMO; and subcutaneous Leqembi could open up access.
https://scrip.citeline.com/SC149266/Quick-Listen-Scrips-Five-MustKnow-Things
https://scrip.citeline.com/SC149266/Quick-Listen-Scrips-Five-MustKnow-Things
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
In God we trust